Contributing Editor Dr. Loretta Nastoupil has a conversation with Dr. Melody Smith about a study that explored whether antibiotic exposure or fecal microbiome composition was associated with efficacy and toxicity following anti-CD19 chimeric antigen receptor T-cell therapy in adult patients with B-cell malignancies.
Lymphohematopoietic Clones: Are They of Unknown Significance, Indeterminate Potential, or Indeterminate Progression?
Dr. Marshall Lichtman looks at the history and direction of the classification of lymphohematopoietic clones.
Drs. Marisol Betensky, John Morrison, Anthony Sochet, and Neil Goldenberg review the treatment and prevention of venous thromboembolism in pediatric patients.
Drs. Bethan Psaila and Mary Frances McMullin provide commentary on a study evaluating the tolerability, safety, and activity of fedratinib combined with ropeginterferon alfa-2β in patients with myelofibrosis.